Andrea S. Blevins Primeau, PhD, MBA

Andrea S. Blevins Primeau, PhD, MBA, is a freelance medical writer and editor based in central Pennsylvania. She enjoys writing about a variety of topics including oncology, cardiovascular disease, and autoimmune disorders. Previously, she conducted research investigating the role of pharmacogenetics on the efficacy of oncologic therapies.

All articles by Andrea S. Blevins Primeau, PhD, MBA

Medicine

Study Reveals High Markup of Cancer Drug Prices and Failure to Disclose Prices Publicly

Andrea S. Blevins Primeau, PhD, MBA

April 27, 2022

The median price markup was as high as 633.6% for 1 drug.

Reviewing test results with a patient with cancer.

Oncology

Nearly 1 in 10 Cancer Patients May Not Receive Guideline-Concordant Care

Andrea S. Blevins Primeau, PhD, MBA

March 25, 2022

The highest rate of non-concordant care was seen in patients with cervical cancer.

Oncology

Variations in Breast Cancer Care Across US Not Explained by Patient Factors

Andrea S. Blevins Primeau, PhD, MBA

February 7, 2022

For all 5 metrics assessed, variation was largely due to unexplained reasons rather than patient factors.

Oncology

COVID-19 Pandemic Did Not Affect Care of Pancreatic Cancer Patients

Andrea S. Blevins Primeau, PhD, MBA

January 21, 2022

Patients with pancreatic ductal adenocarcinoma may have been spared the COVID-related delays in care seen for other cancers, according to researchers.